Related Experiment Video
Updated: Jun 2, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Erin N Howe1, Dawn R Cochrane, Jennifer K Richer
1Program in Cancer Biology, Department of Pathology, University of Colorado, Anschutz Medical Campus, Mail Stop 8104, PO Box 6511, Aurora, CO, USA.
Introduction:
miR-200c and other members of the miR-200 family promote epithelial identity by directly targeting ZEB1 and ZEB2, which repress E-cadherin and other genes involved in polarity. Loss of miR-200c is often observed in carcinoma cells that have undergone epithelial to mesenchymal transition (EMT). Restoration of miR-200c to such cells leads to a reduction in stem cell-like characteristics, reduced migration and invasion, and increased sensitivity to taxanes. Here we investigate the functional role of novel targets of miR-200c in the aggressive behavior of breast and endometrial cancer cells.
Methods:
Putative target genes of miR-200c identified by microarray profiling were validated as direct targets using dual luciferase reporter assays. Following restoration of miR-200c to triple negative breast cancer and type 2 endometrial cancer cell lines that had undergone EMT, levels of endogenous target mRNA and respective protein products were measured. Migration and sensitivity to anoikis were determined using wound healing assays or cell-death ELISAs and viability assays respectively.
Results:
We found that restoration of miR-200c suppresses anoikis resistance, a novel function for this influential miRNA. We identified novel targets of miR-200c, including genes encoding fibronectin 1 (FN1), moesin (MSN), neurotrophic tyrosine receptor kinase type 2 (NTRK2 or TrkB), leptin receptor (LEPR), and Rho GTPase activating protein 19 (ARHGAP19). These targets all encode proteins normally expressed in cells of mesenchymal or neuronal origin; however, in carcinoma cells that lack miR-200c they become aberrantly expressed and contribute to the EMT phenotype and aggressive behavior. We showed that these targets are inhibited upon restoration of miR-200c to aggressive breast and endometrial cancer cells. We demonstrated that inhibition of MSN and/or FN1 is sufficient to mediate the ability of miR-200c to suppress cell migration. Lastly, we showed that targeting of TrkB mediates the ability of miR-200c to restore anoikis sensitivity.
Conclusions:
miR-200c maintains the epithelial phenotype not only by targeting ZEB1/2, which usually facilitates restoration of E-cadherin expression, but also by actively repressing a program of mesenchymal and neuronal genes involved in cell motility and anoikis resistance.
Insights
MicroRNA-200c (miR-200c) restoration suppresses aggressive cancer traits by targeting novel genes, reducing anoikis resistance and cell migration. This microRNA maintains epithelial identity by repressing mesenchymal and neuronal programs.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MicroRNA-200c (miR-200c) is crucial for maintaining epithelial identity by targeting ZEB1 and ZEB2.
- Loss of miR-200c is associated with epithelial to mesenchymal transition (EMT) in carcinoma cells.
- Restoring miR-200c reduces cancer stemness, migration, invasion, and enhances taxane sensitivity.
Purpose of the Study:
- To investigate the functional role of novel miR-200c targets in aggressive breast and endometrial cancer.
- To identify new mechanisms by which miR-200c influences cancer cell behavior.
Main Methods:
- Microarray profiling identified putative miR-200c targets, validated by dual luciferase reporter assays.
- miR-200c was restored in EMT-induced triple-negative breast and type 2 endometrial cancer cell lines.
- mRNA and protein levels, migration, and anoikis sensitivity were measured.
Main Results:
- Restoration of miR-200c suppressed anoikis resistance, a new function for this miRNA.
- Novel miR-200c targets identified include FN1, MSN, NTRK2 (TrkB), LEPR, and ARHGAP19.
- These targets, normally expressed in mesenchymal/neuronal cells, are aberrantly expressed in aggressive carcinoma cells lacking miR-200c.
- Inhibition of MSN and/or FN1 suppressed cell migration; targeting TrkB restored anoikis sensitivity.
Conclusions:
- miR-200c maintains epithelial phenotype by targeting ZEB1/2 and restoring E-cadherin.
- miR-200c actively represses mesenchymal and neuronal genes involved in cell motility and anoikis resistance.
- This dual action contributes to suppressing aggressive cancer cell behavior.
Related Concept Videos
MicroRNAs
MicroRNAs
Microtubules in Cell Motility
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
